Page last updated: 2024-09-03

mosapride and Fasting Hypoglycemia

mosapride has been researched along with Fasting Hypoglycemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoki, K; Kamiyama, H; Masuda, K; Terauchi, Y; Togashi, Y1

Trials

1 trial(s) available for mosapride and Fasting Hypoglycemia

ArticleYear
Mosapride citrate, a 5-HTâ‚„ receptor agonist, increased the plasma active and total glucagon-like peptide-1 levels in non-diabetic men.
    Endocrine journal, 2013, Volume: 60, Issue:4

    Topics: Adult; Benzamides; Blood Glucose; Gastric Inhibitory Polypeptide; Gastrointestinal Agents; Gastrointestinal Tract; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Morpholines; Postprandial Period; Serotonin 5-HT4 Receptor Agonists; Up-Regulation

2013